You may soon be able to add Oregon to the growing number of states with laws that require drug makers to report and justify price hikes for some medicines.

In a bipartisan vote late Friday, the Oregon Senate overwhelmingly passed such a bill, 25-to-4, just a few days after the same legislation was approved by the House. The legislation, called the Prescription Drug Price Transparency Act, now goes to Gov. Kate Brown, who is expected to sign it.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Not that it matters to state legislators, but the VT report is based on WAC list price and is therefore useless for determining what the state or other payers actually paid for these drugs. But at least they “did something.”

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy